Nasdaq Vcel News Today

Vericel (NASDAQ:VCEL – Get Free Report) and Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings. Analyst Recommendations This is a breakdown of recent ratings […]

Louisiana State Employees Retirement System bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 23,900 shares of the biotechnology company’s stock, valued at approximately $851,000. Louisiana State Employees Retirement System owned 0.05% of Vericel […]

CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe...

Truist Financial reissued their buy rating on shares of Vericel (NASDAQ:VCEL – Free Report) in a research note released on Tuesday, Benzinga reports. The firm currently has a $54.00 price target on the biotechnology company’s stock. Other equities analysts also recently issued research reports about the company. HC Wainwright upped their price objective on Vericel […]

Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0...

Vericel Co. (NASDAQ:VCEL – Get Free Report) shares fell 7.4% during mid-day trading on Thursday . The stock traded as low as $43.87 and last traded at $44.27. 384,117 shares traded hands during trading, a decline of 40% from the average session volume of 635,116 shares. The stock had previously closed at $47.80. Wall Street […]

Shares of Vericel Co. (NASDAQ:VCEL – Get Free Report) have been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in […]

Vericel Co. (NASDAQ:VCEL – Get Free Report) shares hit a new 52-week high on Tuesday . The company traded as high as $50.09 and last traded at $49.84, with a volume of 282501 shares changing hands. The stock had previously closed at $49.20. Wall Street Analyst Weigh In A number of brokerages recently commented on […]

Shares of Vericel Co. (NASDAQ:VCEL – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as $50.09 and last traded at $49.84, with a volume of 282501 shares. The stock had previously closed at $49.20. Wall Street Analysts Forecast Growth Several research analysts have commented on […]

Vericel Co. (NASDAQ:VCEL – Get Free Report) Director Robert L. Md Zerbe sold 2,300 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $44.22, for a total transaction of $101,706.00. Following the transaction, the director now directly owns 23,395 shares in […]